IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Northpond Ventures, LLC

Q1 2024 Holdings

Filed 2024-05-15 | 4 holdings | $102.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Kyverna Therapeutics Inc(KYTX)COM501976104$80.9M3,255,42678.8%
Vigil Neuroscience Inc(VIGL)COM92673K108$14.4M4,214,49814.0%
Telesis BIO IncCOM192003101$4.3M9,844,1304.2%
Candel Therapeutics Inc(CADL)COM137404109$3.1M1,935,2153.0%